Cargando…
LC–MS Based Metabolomics Study of the Effects of EGCG on A549 Cells
(−)-Epigallocatechin-3-gallate (EGCG) is the main bioactive catechin in green tea. The antitumor activity of EGCG has been confirmed in various types of cancer, including lung cancer. However, the precise underlying mechanisms are still largely unclear. In the present study, we investigated the meta...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505700/ https://www.ncbi.nlm.nih.gov/pubmed/34650434 http://dx.doi.org/10.3389/fphar.2021.732716 |
_version_ | 1784581589195292672 |
---|---|
author | Pan, Tingyu Han, Di Xu, Yong Peng, Wenpan Bai, Le Zhou, Xianmei He, Hailang |
author_facet | Pan, Tingyu Han, Di Xu, Yong Peng, Wenpan Bai, Le Zhou, Xianmei He, Hailang |
author_sort | Pan, Tingyu |
collection | PubMed |
description | (−)-Epigallocatechin-3-gallate (EGCG) is the main bioactive catechin in green tea. The antitumor activity of EGCG has been confirmed in various types of cancer, including lung cancer. However, the precise underlying mechanisms are still largely unclear. In the present study, we investigated the metabolite changes in A549 cells induced by EGCG in vitro utilizing liquid chromatography-mass spectrometry (LC-MS)-based metabolomics. The result revealed 33 differentially expressed metabolites between untreated and 80 μM EGCG-treated A549 cells. The altered metabolites were involved in the metabolism of glucose, amino acid, nucleotide, glutathione, and vitamin. Two markedly altered pathways, including glycine, serine and threonine metabolism and alanine, aspartate and glutamate metabolism, were identified by MetaboAnalyst 5.0 metabolic pathway analysis. These results may provide potential clues for the intramolecular mechanisms of EGCG’s effect on A549 cells. Our study may contribute to future molecular mechanistic studies of EGCG and the therapeutic application of EGCG in cancer management. |
format | Online Article Text |
id | pubmed-8505700 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85057002021-10-13 LC–MS Based Metabolomics Study of the Effects of EGCG on A549 Cells Pan, Tingyu Han, Di Xu, Yong Peng, Wenpan Bai, Le Zhou, Xianmei He, Hailang Front Pharmacol Pharmacology (−)-Epigallocatechin-3-gallate (EGCG) is the main bioactive catechin in green tea. The antitumor activity of EGCG has been confirmed in various types of cancer, including lung cancer. However, the precise underlying mechanisms are still largely unclear. In the present study, we investigated the metabolite changes in A549 cells induced by EGCG in vitro utilizing liquid chromatography-mass spectrometry (LC-MS)-based metabolomics. The result revealed 33 differentially expressed metabolites between untreated and 80 μM EGCG-treated A549 cells. The altered metabolites were involved in the metabolism of glucose, amino acid, nucleotide, glutathione, and vitamin. Two markedly altered pathways, including glycine, serine and threonine metabolism and alanine, aspartate and glutamate metabolism, were identified by MetaboAnalyst 5.0 metabolic pathway analysis. These results may provide potential clues for the intramolecular mechanisms of EGCG’s effect on A549 cells. Our study may contribute to future molecular mechanistic studies of EGCG and the therapeutic application of EGCG in cancer management. Frontiers Media S.A. 2021-09-28 /pmc/articles/PMC8505700/ /pubmed/34650434 http://dx.doi.org/10.3389/fphar.2021.732716 Text en Copyright © 2021 Pan, Han, Xu, Peng, Bai, Zhou and He. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Pan, Tingyu Han, Di Xu, Yong Peng, Wenpan Bai, Le Zhou, Xianmei He, Hailang LC–MS Based Metabolomics Study of the Effects of EGCG on A549 Cells |
title | LC–MS Based Metabolomics Study of the Effects of EGCG on A549 Cells |
title_full | LC–MS Based Metabolomics Study of the Effects of EGCG on A549 Cells |
title_fullStr | LC–MS Based Metabolomics Study of the Effects of EGCG on A549 Cells |
title_full_unstemmed | LC–MS Based Metabolomics Study of the Effects of EGCG on A549 Cells |
title_short | LC–MS Based Metabolomics Study of the Effects of EGCG on A549 Cells |
title_sort | lc–ms based metabolomics study of the effects of egcg on a549 cells |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505700/ https://www.ncbi.nlm.nih.gov/pubmed/34650434 http://dx.doi.org/10.3389/fphar.2021.732716 |
work_keys_str_mv | AT pantingyu lcmsbasedmetabolomicsstudyoftheeffectsofegcgona549cells AT handi lcmsbasedmetabolomicsstudyoftheeffectsofegcgona549cells AT xuyong lcmsbasedmetabolomicsstudyoftheeffectsofegcgona549cells AT pengwenpan lcmsbasedmetabolomicsstudyoftheeffectsofegcgona549cells AT baile lcmsbasedmetabolomicsstudyoftheeffectsofegcgona549cells AT zhouxianmei lcmsbasedmetabolomicsstudyoftheeffectsofegcgona549cells AT hehailang lcmsbasedmetabolomicsstudyoftheeffectsofegcgona549cells |